rs372229079

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_005449.5(FCMR):​c.1009G>A​(p.Gly337Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000056 in 1,285,816 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000058 ( 2 hom. )

Consequence

FCMR
NM_005449.5 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.10

Publications

0 publications found
Variant links:
Genes affected
FCMR (HGNC:14315): (Fc mu receptor) Fc receptors specifically bind to the Fc region of immunoglobulins (Igs) to mediate the unique functions of each Ig class. FAIM3 encodes an Fc receptor for IgM (see MIM 147020) (Kubagawa et al., 2009 [PubMed 19858324]; Shima et al., 2010 [PubMed 20042454]).[supplied by OMIM, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03535652).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FCMRNM_005449.5 linkc.1009G>A p.Gly337Ser missense_variant Exon 7 of 8 ENST00000367091.8 NP_005440.1 O60667-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FCMRENST00000367091.8 linkc.1009G>A p.Gly337Ser missense_variant Exon 7 of 8 1 NM_005449.5 ENSP00000356058.3 O60667-1

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152130
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
1246
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000582
AC:
66
AN:
1133576
Hom.:
2
Cov.:
30
AF XY:
0.0000629
AC XY:
34
AN XY:
540616
show subpopulations
African (AFR)
AF:
0.0000431
AC:
1
AN:
23192
American (AMR)
AF:
0.00
AC:
0
AN:
8616
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15554
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26678
South Asian (SAS)
AF:
0.00167
AC:
57
AN:
34046
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25574
Middle Eastern (MID)
AF:
0.000280
AC:
1
AN:
3572
European-Non Finnish (NFE)
AF:
0.00000105
AC:
1
AN:
950290
Other (OTH)
AF:
0.000130
AC:
6
AN:
46054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152240
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41556
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67986
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.567
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000187
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.000207
AC:
9
Asia WGS
AF:
0.00347
AC:
12
AN:
3472

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 12, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1009G>A (p.G337S) alteration is located in exon 7 (coding exon 7) of the FCMR gene. This alteration results from a G to A substitution at nucleotide position 1009, causing the glycine (G) at amino acid position 337 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
2.3
DANN
Benign
0.97
DEOGEN2
Benign
0.051
T;.
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.62
T;T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.035
T;T
MetaSVM
Benign
-0.99
T
PhyloP100
-1.1
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
0.23
N;N
REVEL
Benign
0.016
Sift
Benign
0.36
T;T
Sift4G
Benign
0.67
T;T
Polyphen
0.024
B;.
Vest4
0.078
MutPred
0.087
Gain of glycosylation at G337 (P = 0.0012);.;
MVP
0.12
MPC
0.22
ClinPred
0.29
T
GERP RS
-0.96
Varity_R
0.037
gMVP
0.091
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372229079; hg19: chr1-207082842; API